Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Haleon PLC AGM Information 2025

Apr 4, 2025

5111_ffr_2025-04-04_17f81cf5-9deb-470f-888f-ad32f011a2e9.zip

AGM Information

Open in viewer

Opens in your device viewer

6-K 1 a7698d.htm NOTICE OF ANNUAL GENERAL MEETING (AGM) Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com Copyright 2025 Issuer Direct Corporation a7698d

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2025

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

| Exhibit
Number | Description |
| --- | --- |
| 99.1 | 04
April 2025 - Notice of Annual General Meeting (AGM) |

99.1

Haleon plc: Notice of Annual General Meeting (AGM)

4 April 2025: Haleon plc (the "Company" or "Haleon") today announces that the following documents have been made available to shareholders:

  1. Notice of 2025 Annual General Meeting (the "Notice");

  2. Form of Proxy for 2025 Annual General Meeting; and

  3. AGM Voting Instruction Card.

Haleon's AGM will again be a virtual meeting, broadcast under studio conditions from the Company's London offices at 3.00pm (BST) on Wednesday 28 May 2025. The Notice is available on the Company's website at https://www.haleon.com/investors/shareholder-information/annual-general-meetings , and includes full details of the business to be conducted and joining instructions.

In compliance with UK Listing Rule 6.4.1R, a copy of the above documents has been submitted to the National Storage Mechanism and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism .

Amanda Mellor

Company Secretary

Enquiries

Investors — Jo Russell +44 7787 392441 Media — Zoë Bird +44 7736 746167
Rakesh Patel +44 7552 484646 Victoria Durman +44 7894 505730
Emma White +44 7823 523562
Email: [email protected] Email: [email protected]

About Haleon

Haleon (LSE / NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans five major categories - Oral Health, Pain Relief, Respiratory Health, Digestive Health and Other, and Vitamins, Minerals and Supplements (VMS). Its long-standing brands - such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax and Centrum - are built on trusted science, innovation and deep human understanding.

For more information, please visit www.haleon.com .

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| HALEON PLC (Registrant) — /s/
Amanda Mellor | |
| --- | --- |
| Name: | Amanda
Mellor |
| Title: | Company
Secretary |

page break